Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
05 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alteogens-tergase-novel-recombinant-human-hyaluronidase-injection-shows-excellent-immunogenicity-profile-301916724.html
22 Feb 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/altos-biologics-a-subsidiary-of-alteogen-completed-patient-enrollment-in-global-phase-3-clinical-trial-of-eylea-biosimilar-in-neovascular-age-related-macular-degeneration-301752666.html
03 Jan 2023
// BUSINESSWIRE
08 Mar 2021
// BUSINESSWIRE
https://www.businesswire.com/news/home/20210308005025/en/Alteogen-Announces-Completion-of-Phase-1-Clinical-Trial-of-Aflibercept-Biosimilar-in-Wet-AMD-Patients#:~:text=DAEJEON%2C%20South%20Korea%2D%2D(BUSINESS,Biosimilar%20(ALT%2DL9).&text=Eylea%C2%AE%20is%20a%20drug,along%20with%20cataracts%20and%20glaucoma.
08 Mar 2021
// BUSINESSWIRE
07 Jan 2021
// BUSINESSWIRE
https://www.businesswire.com/news/home/20210107005327/en/Alteogen-Enters-Into-an-Exclusive-License-Agreement-With-Intas-to-Develop-and-Commercialize-Two-Products-Enabled-by-Its-Hybrozyme%E2%84%A2-Technology#:~:text=Business%20Wire-,Alteogen%20Enters%20Into%20an%20Exclusive%20License%20Agreement%20With%20Intas%20to,by%20Its%20Hybrozyme%E2%84%A2%20Technology&text=Under%20the%20terms%20of%20the,in%20combination%20with%20ALT%2DB4.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?